Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com ), focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced its has produced a new edition of Corporate Profile, which is used to answer inquiries about the Company from brokers, investors and other interested individuals.
The Corporate Profile is available at http://www.cordblood-america.com/3-8-2010%20investor%20profile.pdf
"The Corporate Profile carefully details the Company's Overview, Business Strategies and Products. It gives details on the Corporate Management and Recent Accomplishments and provides financial and other details about the Company and outlines its Mission, We recommend it for anyone doing due diligence on Cord Blood America," said Matthew Schissler, co-founder and CEO.
Key kinase involved in cell division linked to abnormal blood vessel growth in genetic disorder